BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/24/2020 2:27:20 AM | Browse: 825 | Download: 1645
 |
Received |
|
2020-06-28 03:10 |
 |
Peer-Review Started |
|
2020-06-28 03:11 |
 |
First Decision by Editorial Office Director |
|
2020-07-28 21:22 |
 |
Return for Revision |
|
2020-07-28 21:22 |
 |
Revised |
|
2020-08-07 02:11 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-09-16 12:25 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-09-17 04:51 |
 |
Articles in Press |
|
2020-09-17 04:51 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2020-09-22 13:53 |
 |
Publish the Manuscript Online |
|
2020-10-24 02:27 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff and Mishal Mendiratta-Lala |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anum Aslam, MD, Assistant Professor, Department of Radiology, University of Michigan, 1500 E. Medical Center Dr, Ann Arbor, MI 48019, United States. aanum@med.umich.edu |
| Key Words |
Hepatocellular carcinoma; Liver Imaging Reporting and Data Systems Treatment Response Algorithm; Locoregional therapy; Liver Imaging Reporting and Data Systems Treatment Response equivocal; Arterial phase hyper enhancement; Stereotactic body radiotherapy |
| Core Tip |
Liver Imaging Reporting and Data Systems (LI-RADS) Treatment Response Algorithm (TRA) provides a new framework to describe treatment response for each individually treated hepatocellular carcinoma (HCC). Emerging evidence for its use in clinical practice is promising for ablation and non-radiation arterial-based therapies (i.e., transarterial chemoembolization). However, LI-RADS TRA should be applied cautiously when assessing HCC treated with radiation-based therapies (i.e., transarterial radioembolization, stereotactic body radiotherapy), in which early post-treatment persistent arterial phase hyperenhancement is common, and expected, and can confound treatment response. |
| Publish Date |
2020-10-24 02:27 |
| Citation |
Aslam A, Do RKG, Kambadakone A, Spieler B, Miller FH, Gabr AM, Charalel RA, Kim CY, Madoff DC, Mendiratta-Lala M. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World J Hepatol 2020; 12(10): 738-753 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i10/738.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i10.738 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.